The Brain Tumor Funders' Collaborative: Immunotherapy for primary human brain tumors (Pre- proposals)

Interested in gaining a better understanding of immune mechanisms as they apply to human brain tumors of any grade in pediatric and adult populations. Characterization across more than one tumor type, therapeutic approach, and age group are of interest.

Funding: maximum of $250,000/year for 3 years.

The Lead institution must be a U.S. non-profit institution or equivalent Canadian institution or a state university. (No overhead)

http://www.braintumorfunders.org/2018rfp.htm